Xinghao Ai, Yan Yu, Tongmei Zhang, Tienan Yi, Mingjun Li, Wenxiu Yao, Liang Han, Longhua Sun, Anwen Liu, Qi Mei, Guang Han, Zhen Zhang, Yinyin Li, Lu Li, Li Zheng, Yong Fang, Yongzhong Luo, Binhua Lv, Andrew X. Zhu, Shun Lu. "Updated results of the randomized phase 2 dose optimization study of alveltamig (ZG006), a trispecific T cell engager targeting DLL3/DLL3/CD3, as monotherapy in patients with advanced small cell lung cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8109